RELXRelx
About Relx
Relx (LSE:REL), (EURONEXT:RELX), (NYSE:RELX) specializes in providing information-based analytics and decision tools for professional and business customers across various industries. The company operates through four primary segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. Their projects and services aim to help clients analyze, evaluate, and improve their professional decision-making processes, leveraging vast databases and technological tools for insights across healthcare, science, law, risk management, and more. Relx strives to innovate and expand its digital solutions and datasets to meet evolving market needs, with a strong commitment to reliability, accuracy, and utility in the information it provides. The company's objective is to support its customers in making more informed decisions, advancing science, and delivering better outcomes for society.
What is RELX known for?
Snapshot
Public US
Ownership
1903
Year founded
2482
Employees
London, United Kingdom
Head office
1 of 4
US Rank
Unknown
Sector
N/A
Sector rank
Loading Map...
Operations
All Locations
United Kingdom of Great Britain and Northern Ireland
Products and/or services of Relx
- Scientific, technical, and medical information tools are among the core services, providing critical data for research and development.
- Legal professionals benefit from indispensable digital legal solutions with access to extensive legal databases.
- Risk-based analytics and insights help businesses mitigate threats, ensuring overall business health and continuity.
- Asset management data capture supports owners and operators in crucial maintenance and repair operations.
- Creating predictive analytics and decision tools gives significant insights for scientists, healthcare professionals and insurance underwriters.
- Healthcare professionals gain advanced electronic health records, practice management, and electronic prescribing solutions.
Relx executive team
- Mr. Erik Engstrom M.Sc Econ, M.Sc Eng., MBACEO & Executive Director
- Mr. Nicholas Lawrence LuffCFO & Executive Director
- Ms. Kumsal Bayazit BessonChief Executive Officer of Scientific, Technical & Medical
- Mr. Colin TennantHead of Investor Relations
- Mr. Henry Adam Udow IV, J.D.Chief Legal Officer & Company Secretary
- Mr. Paul AbrahamsHead of Corporate Communications
- Ms. Rosemary ThomsonChief Human Resources Officer
- Mr. Mark KelseyChief Executive Officer of Risk
- Dr. Márcia BaliscianoGlobal Head of Corporate Responsibility
- Mr. Michael WalshChief Executive Officer of Legal